Nuvectis Pharma Quote - NVCT

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

6.76

Bid

6.36

Ask

7.00

Volume

42,106

6.565 Day's Range 6.88

4.44 52 Week Range 12.10

Market Cap

130.61M

Previous Close

6.74

Open

6.86

Last Trade

134

6.76

(formt)

Last Trade Time

Financial Volume

US$ 282,823

VWAP

6.7169

Average Volume (3m)

160,859

Shares Outstanding

19,320,973

Dividend Yield

PE Ratio

-5.84

Earnings Per Share (EPS)

-1.15

Revenue

Net Profit

-22.26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nuvectis.com

Headquarters

Wilmington, Delaware, USA

Founded

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was US$6.74. Over the last year, Nuvectis Pharma shares have traded in a share price range of US$ 4.44 to US$ 12.10.

Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is US$130.22 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -5.84.

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.27	4.16024653313	6.49	7.15	6.12	94438	6.52532176	CS
4	1.25	22.6860254083	5.51	7.15	5.32	97309	6.13184165	CS
12	-1.68	-19.9052132701	8.44	11.8	4.44	160859	6.21272613	CS
26	0.2	3.0487804878	6.56	11.8	4.44	137188	6.64033073	CS
52	-0.51	-7.015130674	7.27	12.1	4.44	113016	7.02925645	CS
156	2.81	71.1392405063	3.95	20.92	3.08	186185	7.81165304	CS
260	2.81	71.1392405063	3.95	20.92	3.08	186185	7.81165304	CS

NVCT - Frequently Asked Questions (FAQ)

What is the current Nuvectis Pharma share price?

The current share price of Nuvectis Pharma is US$ 6.76

How many Nuvectis Pharma shares are in issue?

Nuvectis Pharma has 19,320,973 shares in issue

What is the market cap of Nuvectis Pharma?

The market capitalisation of Nuvectis Pharma is USD 130.22M

What is the 1 year trading range for Nuvectis Pharma share price?

Nuvectis Pharma has traded in the range of US$ 4.44 to US$ 12.10 during the past year

What is the PE ratio of Nuvectis Pharma?

The price to earnings ratio of Nuvectis Pharma is -5.84

What is the reporting currency for Nuvectis Pharma?

Nuvectis Pharma reports financial results in USD

What is the latest annual profit for Nuvectis Pharma?

The latest annual profit of Nuvectis Pharma is USD -22.26M

What is the registered address of Nuvectis Pharma?

The registered address for Nuvectis Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Nuvectis Pharma website address?

The website address for Nuvectis Pharma is www.nuvectis.com

Which industry sector does Nuvectis Pharma operate in?

Nuvectis Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.5M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	341.8M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	237.15M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.44M